Correlation Between Oncolytics Biotech and T2 Metals
Can any of the company-specific risk be diversified away by investing in both Oncolytics Biotech and T2 Metals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncolytics Biotech and T2 Metals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncolytics Biotech and T2 Metals Corp, you can compare the effects of market volatilities on Oncolytics Biotech and T2 Metals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncolytics Biotech with a short position of T2 Metals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncolytics Biotech and T2 Metals.
Diversification Opportunities for Oncolytics Biotech and T2 Metals
0.84 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Oncolytics and TWO is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding Oncolytics Biotech and T2 Metals Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on T2 Metals Corp and Oncolytics Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncolytics Biotech are associated (or correlated) with T2 Metals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of T2 Metals Corp has no effect on the direction of Oncolytics Biotech i.e., Oncolytics Biotech and T2 Metals go up and down completely randomly.
Pair Corralation between Oncolytics Biotech and T2 Metals
Assuming the 90 days trading horizon Oncolytics Biotech is expected to under-perform the T2 Metals. But the stock apears to be less risky and, when comparing its historical volatility, Oncolytics Biotech is 1.43 times less risky than T2 Metals. The stock trades about -0.01 of its potential returns per unit of risk. The T2 Metals Corp is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 40.00 in T2 Metals Corp on November 1, 2024 and sell it today you would lose (19.00) from holding T2 Metals Corp or give up 47.5% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Oncolytics Biotech vs. T2 Metals Corp
Performance |
| Timeline |
| Oncolytics Biotech |
| T2 Metals Corp |
Oncolytics Biotech and T2 Metals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Oncolytics Biotech and T2 Metals
The main advantage of trading using opposite Oncolytics Biotech and T2 Metals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncolytics Biotech position performs unexpectedly, T2 Metals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in T2 Metals will offset losses from the drop in T2 Metals' long position.| Oncolytics Biotech vs. Theratechnologies | Oncolytics Biotech vs. Aptose Biosciences | Oncolytics Biotech vs. Resverlogix Corp |
| T2 Metals vs. Information Services | T2 Metals vs. NextSource Materials | T2 Metals vs. Diamond Estates Wines | T2 Metals vs. Verizon Communications CDR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Stocks Directory Find actively traded stocks across global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |